Matrixx Opens Door For Plaintiffs, But Only A Crack
The U.S. Supreme Court ruled Tuesday that drug companies must disclose adverse event reports if they could affect the company's share price, a decision attorneys say could make it more difficult...To view the full article, register now.
Already a subscriber? Click here to view full article